These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 14593699

  • 21. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34.
    van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, van den Ouweland A, Halley D, Young J, Burley M, Jeremiah S, Woodward K, Nahmias J, Fox M, Ekong R, Osborne J, Wolfe J, Povey S, Snell RG, Cheadle JP, Jones AC, Tachataki M, Ravine D, Sampson JR, Reeve MP, Richardson P, Wilmer F, Munro C, Hawkins TL, Sepp T, Ali JB, Ward S, Green AJ, Yates JR, Kwiatkowska J, Henske EP, Short MP, Haines JH, Jozwiak S, Kwiatkowski DJ.
    Science; 1997 Aug 08; 277(5327):805-8. PubMed ID: 9242607
    [Abstract] [Full Text] [Related]

  • 22. Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder.
    Knowles MA, Habuchi T, Kennedy W, Cuthbert-Heavens D.
    Cancer Res; 2003 Nov 15; 63(22):7652-6. PubMed ID: 14633685
    [Abstract] [Full Text] [Related]

  • 23. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
    Kerfoot C, Wienecke R, Menchine M, Emelin J, Maize JC, Welsh CT, Norman MG, DeClue JE, Vinters HV.
    Brain Pathol; 1996 Oct 15; 6(4):367-75. PubMed ID: 8944308
    [Abstract] [Full Text] [Related]

  • 24. Tuberin activates the proapoptotic molecule BAD.
    Freilinger A, Rosner M, Krupitza G, Nishino M, Lubec G, Korsmeyer SJ, Hengstschläger M.
    Oncogene; 2006 Oct 19; 25(49):6467-79. PubMed ID: 16702951
    [Abstract] [Full Text] [Related]

  • 25. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination.
    Benvenuto G, Li S, Brown SJ, Braverman R, Vass WC, Cheadle JP, Halley DJ, Sampson JR, Wienecke R, DeClue JE.
    Oncogene; 2000 Dec 14; 19(54):6306-16. PubMed ID: 11175345
    [Abstract] [Full Text] [Related]

  • 26. Sacrococcygeal chordomas in patients with tuberous sclerosis complex show somatic loss of TSC1 or TSC2.
    Lee-Jones L, Aligianis I, Davies PA, Puga A, Farndon PA, Stemmer-Rachamimov A, Ramesh V, Sampson JR.
    Genes Chromosomes Cancer; 2004 Sep 14; 41(1):80-5. PubMed ID: 15236319
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Expression and prognostic value of tuberous sclerosis complex 2 gene product tuberin in human pancreatic cancer.
    Kataoka K, Fujimoto K, Ito D, Koizumi M, Toyoda E, Mori T, Kami K, Doi R.
    Surgery; 2005 Sep 14; 138(3):450-5. PubMed ID: 16213898
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Tuberous sclerosis-related gene expression in normal and dysplastic brain.
    Vinters HV, Kerfoot C, Catania M, Emelin JK, Roper SN, DeClue JE.
    Epilepsy Res; 1998 Sep 14; 32(1-2):12-23. PubMed ID: 9761305
    [Abstract] [Full Text] [Related]

  • 34. Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex.
    Ali M, Girimaji SC, Markandaya M, Shukla AK, Sacchidanand S, Kumar A.
    Acta Neurol Scand; 2005 Jan 14; 111(1):54-63. PubMed ID: 15595939
    [Abstract] [Full Text] [Related]

  • 35. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.
    Astrinidis A, Henske EP.
    Oncogene; 2005 Nov 14; 24(50):7475-81. PubMed ID: 16288294
    [Abstract] [Full Text] [Related]

  • 36. Deletion of 11 amino acids in tuberin associated with severe tuberous sclerosis phenotypes: evidence for a new essential domain in the first third of the protein.
    Jobert S, Bragado-Nilsson E, Samolyk D, Pedespan JM, Marchal C, Reichert S, Mallet J, Pitiot G.
    Eur J Hum Genet; 1997 Nov 14; 5(5):280-7. PubMed ID: 9412784
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Antisense suppression of TSC1 gene product, hamartin, enhances neurite outgrowth in NGF-treated PC12h cells.
    Floricel F, Higaki K, Maki H, Nanba E, Ninomiya H, Ohno K.
    Brain Dev; 2007 Sep 14; 29(8):502-9. PubMed ID: 17376623
    [Abstract] [Full Text] [Related]

  • 40. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
    Rendtorff ND, Bjerregaard B, Frödin M, Kjaergaard S, Hove H, Skovby F, Brøndum-Nielsen K, Schwartz M, Danish Tuberous Sclerosis Group.
    Hum Mutat; 2005 Oct 14; 26(4):374-83. PubMed ID: 16114042
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.